Silvia Vaienti

Dr. Silvia Vaienti


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2025 in Cancers
Verified
Journal Article
Open access
PDF file
Fortunato CassaliaFortunato Cassalia
Fortunato Cassalia
ADAndrea Danese
Andrea Danese
Enrico CocchiEnrico Cocchi
Enrico Cocchi
SVSilvia Vaienti
Silvia Vaienti
ABAnna Bolzon
Anna Bolzon
Anna Belloni FortinaAnna Belloni Fortina
Anna Belloni Fortina
Dermatofibrosarcoma protuberans (DFSP) is a rare, low-grade sarcoma that presents diagnostic challenges due to its resemblance to benign lesions

5 November 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
Fortunato CassaliaFortunato Cassalia
Fortunato Cassalia
ADAndrea Danese
Andrea Danese
Enrico CocchiEnrico Cocchi
Enrico Cocchi
SVSilvia Vaienti
Silvia Vaienti
ABAnna Bolzon
Anna Bolzon
Anna Belloni FortinaAnna Belloni Fortina
Anna Belloni Fortina
Congenital Dermatofibrosarcoma Protuberans (DFSP) is an extremely rare low-grade soft tissue sarcoma arising from the dermis. Accounting for less than 0.1% of all malignancies and approximately 1% of soft tissue sarcomas, congenital DFSP presents a significant diagnostic challenge due to its atypical presentation in neonates and infants. Often mimicking benign skin lesions such as hemangiomas, vascular malformations or pigmented moles, it is frequently misdiagnosed, leading to delays in appropriate treatment. This narrative review highlights the importance of early recognition and accurate diagnosis of congenital DFSP to prevent aggressive local growth and reduce the risk of recurrence. We discuss the epidemiology, clinical presentation and diagnostic hurdles associated with this condition. Histopathological examination remains the gold standard for diagnosis, with characteristic findings of spindle-shaped cells in a storiform pattern and strong CD34 positivity on immunohistochemical staining. Imaging modalities such as MRI may be helpful in assessing the extent of the lesion. Surgical excision with clear margins, preferably using Mohs micrographic surgery, is the cornerstone of treatment, balancing oncological control with functional and aesthetic considerations in paediatric patients. A multidisciplinary approach involving dermatologists, paediatric surgeons, oncologists and pathologists is essential for optimal management. We also emphasise the need for clinician vigilance, early biopsy of suspicious lesions, patient education and long-term follow-up to improve outcomes and quality of life for affected children.